Cancer prevention by green tea: Evidence from epidemiologic studies 1-4

American Journal of Clinical Nutrition

Volumn 98, Issue 6, 2013, Pages

  Yuan, Jian Min ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; AFLATOXIN B1; CATECHIN; CATECHOL METHYLTRANSFERASE; EPICATECHIN; EPIGALLOCATECHIN; GREEN TEA EXTRACT; HEPATITIS B SURFACE ANTIGEN; POLYPHENOL; POLYPHENON E; PROSTATE SPECIFIC ANTIGEN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; VASCULOTROPIN;

ARTICLE; BEVERAGE; BREAST CANCER; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CATECHOL METHYLTRANSFERASE GENE; COLORECTAL CANCER; DENSITY; DNA DAMAGE; DOSE RESPONSE; DRINKING BEHAVIOR; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG URINE LEVEL; ESOPHAGUS CANCER; FOLLOW UP; FOOD INTAKE; GENE; GENETIC POLYMORPHISM; HEPATITIS B; HIGH TEMPERATURE; HIGH TEMPERATURE BEVERAGE; HISTOLOGY; HUMAN; LEUKOPLAKIA; LIVER CANCER; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; MAMMOGRAPHIC DENSITY; MAMMOGRAPHY; META ANALYSIS (TOPIC); MOUTH CANCER; PHASE 2 CLINICAL TRIAL (TOPIC); PLANT LEAF; PRECANCER; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKING; STOMACH CANCER; SYSTEMATIC REVIEW (TOPIC); TUMOR VOLUME;

ANIMALS; BREAST NEOPLASMS; CAMELLIA SINENSIS; EPIDEMIOLOGIC STUDIES; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MOUTH NEOPLASMS; NEOPLASMS; PHYTOTHERAPY; PLANT EXTRACTS; POLYPHENOLS; PROSTATIC NEOPLASMS; TEA;

EID: 84888211017     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.113.058271     Document Type: Article

References (52)

1. Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prev Med 1992;21:334-350
2. Yang CS, Wang X, Lu G, Picinich SC. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 2009;9:429-439
3. Oba S, Nagata C, Nakamura K, Fujii K, Kawachi T, Takatsuka N, Shimizu H. Consumption of coffee, green tea, oolong tea, black tea, chocolate snacks and the caffeine content in relation to risk of diabetes in Japanese men and women. Br J Nutr 2010;103:453-459
4. Yang CS,Wang H. Mechanistic issues concerning cancer prevention by tea catechins. Mol Nutr Food Res 2011;55:819-831
5. Yuan JM. Green tea and prevention of esophageal and lung cancers. Mol Nutr Food Res 2011;55:886-904
6. Yuan J-M, Sun C, Butler LM. Tea and cancer prevention: epidemiological studies. Pharmacol Res 2011;64:123-135
7. Li N, Sun Z, Han C, Chen J. The chemopreventive effects of tea on human oral precancerous mucosa lesions. Proc Soc Exp Biol Med 1999;220:218-224
8. Tsao AS, Liu D, Martin J, Tang XM, Lee JJ, El-Naggar AK, Wistuba I, Culotta KS, Mao L, Gillenwater A, et al. Phase 2 randomized, placebocontrolled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prev Res (Phila) 2009;2:931-941
9. Brunning DA. Letter: oesophageal cancer and hot tea. Lancet 1974;1:272
10. Islami F, Boffetta P, Ren JS, Pedoeim L, Khatib D, Kamangar F. Hightemperature beverages and foods and esophageal cancer risk -a systematic review. Int J Cancer 2009;125:491-524
11. Blot WJ, McLaughlin JK, Fraumeni JF Jr. Esophageal cancer. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention. New York, NY: Oxford University Press, 2006:697-706
12. Fan Y, Yuan J-M, Wang R, Gao YT, Yu MC. Alcohol, tobacco, and diet in relation to esophageal cancer: the Shanghai Cohort Study. Nutr Cancer 2008;60:354-363
13. Gao YT, McLaughlin JK, Blot WJ, Ji BT, Dai Q, Fraumeni JF Jr. Reduced risk of esophageal cancer associated with green tea consumption. J Natl Cancer Inst 1994;86:855-858
14. Wu M, Liu AM, Kampman E, Zhang ZF, Van't Veer P, Wu DL, Wang PH, Yang J, Qin Y, Mu LN, et al. Green tea drinking, high tea temperature and esophageal cancer in high- And low-risk areas of Jiangsu Province, China: a population-based case-control study. Int J Cancer 2009;124:1907-1913
15. Myung SK, Bae WK, Oh SM, Kim Y, Ju W, Sung J, Lee YJ, Ko JA, Song JI, Choi HJ. Green tea consumption and risk of stomach cancer: a meta-analysis of epidemiologic studies. Int J Cancer 2009;124:670-677
16. Inoue M, Sasazuki S, Wakai K, Suzuki T, Matsuo K, Shimazu T, Tsuji I, Tanaka K, Mizoue T, Nagata C, et al. Green tea consumption and gastric cancer in Japanese: a pooled analysis of six cohort studies. Gut 2009;58:1323-1332
17. Deandrea S, Foschi R, Galeone C, La Vecchia C, Negri E, Hu J. Is temperature an effect modifier of the association between green tea intake and gastric cancer risk? Eur J Cancer Prev 2010;19:18-22
18. Sun CL,Yuan J-M, LeeMJ,YangCS, GaoYT, Ross RK,YuMC. Urinary tea polyphenols in relation to gastric and esophageal cancers: a prospective study of men in Shanghai, China. Carcinogenesis 2002;23:1497-1503
19. Sun CL, Yuan J-M, Koh WP, Yu MC. Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis 2006;27:1301-1309
20. Sun CL, Yuan J-M, Koh WP, Lee HP, Yu MC. Green tea and black tea consumption in relation to colorectal cancer risk: the Singapore Chinese Health Study. Carcinogenesis 2007;28:2143-2148
21. Yang G, Shu XO, Li H, Chow WH, Ji BT, Zhang X, Gao YT, ZhengW. Prospective cohort study of green tea consumption and colorectal cancer risk in women. Cancer Epidemiol Biomarkers Prev 2007;16:1219-1223
22. Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugane S. Coffee consumption and risk of colorectal cancer in a population-based prospective cohort of Japanese men and women. Int J Cancer 2007;121:1312-1318
23. Suzuki E, Yorifuji T, Takao S, Komatsu H, Sugiyama M, Ohta T, Ishikawa-Takata K, Doi H. Green tea consumption and mortality among Japanese elderly people: the prospective Shizuoka elderly cohort. Ann Epidemiol 2009;19:732-739
24. Yuan J-M, Gao YT, Yang CS, Yu MC. Urinary biomarkers of tea polyphenols and risk of colorectal cancer in the Shanghai Cohort Study. Int J Cancer 2007;120:1344-1350
25. Wang N, Zheng Y, Jiang Q, Yu X, Chen Y. Tea and reduced liver cancer mortality. Epidemiology 2008;19:761
26. Ui A, Kuriyama S, Kakizaki M, Sone T, Nakaya N, Ohmori-Matsuda K, Hozawa A, Nishino Y, Tsuji I. Green tea consumption and the risk of liver cancer in Japan: the Ohsaki Cohort Study. Cancer Causes Control 2009;20:1939-1945
27. Inoue M, Kurahashi N, Iwasaki M, Shimazu T, Tanaka Y, Mizokami M, Tsugane S. Effect of coffee and green tea consumption on the risk of liver cancer: cohort analysis by hepatitis virus infection status. Cancer Epidemiol Biomarkers Prev 2009;18:1746-1753
28. Yu MC, Yuan J-M, Govindarajan S, Ross RK. Epidemiology of hepatocellular carcinoma. Can J Gastroenterol 2000;14:703-709
29. Tang L, Tang M, Xu L, Luo H, Huang T, Yu J, Zhang L, Gao W, Cox SB, Wang JS. Modulation of aflatoxin biomarkers in human blood and urine by green tea polyphenols intervention. Carcinogenesis 2008;29:411-417
30. Luo H, Tang L, Tang M, Billam M, Huang T, Yu J, Wei Z, Liang Y, Wang K, Zhang ZQ, et al. Phase IIa chemoprevention trial of green tea polyphenols in high-risk individuals of liver cancer: modulation of urinary excretion of green tea polyphenols and 8-hydroxydeoxyguanosine. Carcinogenesis 2006;27:262-268
31. Zhong L, Goldberg MS, Gao YT, Hanley JA, Parent ME, Jin F. A population-based case-control study of lung cancer and green tea consumption among women living in Shanghai, China. Epidemiology 2001;12:695-700
32. Tang N, Wu Y, Zhou B, Wang B, Yu R. Green tea, black tea consumption and risk of lung cancer: a meta-analysis. Lung Cancer 2009;65:274-283
33. Jian L, Xie LP, Lee AH, Binns CW. Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int J Cancer 2004;108:130-135
34. Sonoda T, Nagata Y, Mori M, Miyanaga N, Takashima N, Okumura K, Goto K, Naito S, Fujimoto K, Hirao Y, et al. A case-control study of diet and prostate cancer in Japan: possible protective effect of traditional Japanese diet. Cancer Sci 2004;95:238-242
35. Severson RK, Nomura AM, Grove JS, Stemmermann GN. A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 1989;49:1857-1860
36. Allen NE, Sauvaget C, Roddam AW, Appleby P, Nagano J, Suzuki G, Key TJ, Koyama K. A prospective study of diet and prostate cancer in Japanese men. Cancer Causes Control 2004;15:911-920
37. Kikuchi N, Ohmori K, Shimazu T, Nakaya N, Kuriyama S, Nishino Y, Tsubono Y, Tsuji I. No association between green tea and prostate cancer risk in Japanese men: the Ohsaki Cohort Study. Br J Cancer 2006;95:371-373
38. Kurahashi N, Sasazuki S, Iwasaki M, Inoue M, Tsugane S, Group JS. Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am J Epidemiol 2008;167:71-77
39. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-ofprinciple study. Cancer Res 2006;66:1234-1240
40. McLarty J, Bigelow RL, Smith M, Elmajian D, Ankem M, Cardelli JA. Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro. Cancer Prev Res (Phila) 2009;2:673-682
41. Jatoi A, Ellison N, Burch PA, Sloan JA, Dakhil SR, Novotny P, Tan W, Fitch TR, Rowland KM, Young CY, et al. A phase 2 trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer 2003;97:1442-1446
42. Choan E, Segal R, Jonker D, Malone S, Reaume N, Eapen L, Gallant V. A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach. Urol Oncol 2005;23:108-113
43. Nguyen MM, Ahmann FR, Nagle RB, Hsu CH, Tangrea JA, Parnes HL, Sokoloff MH, Gretzer MB, Chow HH. Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities. Cancer Prev Res (Phila) 2012;5:290-298
44. Brausi M, Rizzi F, Bettuzzi S. Chemoprevention of human prostate cancer by green tea catechins: two years later. A follow-up update. Eur Urol 2008;54:472-473
45. Wu AH, Butler LM. Green tea and breast cancer. Mol Nutr Food Res 2011;55:921-930
46. Luo J, Gao YT, Chow WH, Shu XO, Li H, Yang G, Cai Q, Rothman N, Cai H, Shrubsole MJ, et al. Urinary polyphenols and breast cancer risk: results from the Shanghai Women's Health Study. Breast Cancer Res Treat 2010;120:693-702
47. Iwasaki M, Inoue M, Sasazuki S, Miura T, Sawada N, Yamaji T, Shimazu T, Willett WC, Tsugane S. Plasma tea polyphenol levels and subsequent risk of breast cancer among Japanese women: a nested case-control study. Breast Cancer Res Treat 2010;124:827-834
48. Galli A, Svegliati-Baroni G, Ceni E, Milani S, Ridolfi F, Salzano R, Tarocchi M, Grappone C, Pellegrini G, Benedetti A, et al. Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism. Hepatology 2005;41:1074-1084
49. Inoue-Choi M, Yuan JM, Yang CS, Van Den Berg DJ, Lee MJ, Gao YT, Yu MC. Genetic association between the COMT genotype and urinary levels of tea polyphenols and their metabolites among daily green tea drinkers. Int J Mol Epidemiol Genet 2010;1:114-123
50. Wu AH, Tseng CC, Van Den Berg D, Yu MC. Tea intake, COMT genotype, and breast cancer in Asian-American women. Cancer Res 2003;63:7526-7529
51. Shrubsole MJ, Lu W, Chen Z, Shu XO, Zheng Y, Dai Q, Cai Q, Gu K, Ruan ZX, Gao YT, et al. Drinking green tea modestly reduces breast cancer risk. J Nutr 2009;139:310-316
52. Yang CS, Wang H, Li GX, Yang Z, Guan F, Jin H. Cancer prevention by tea: evidence from laboratory studies. Pharmacol Res 2011;64:113-122